通过对IGF2BP2的抑制,通过降低Spon2基因的调节,克服了肺癌中西斯普拉丁耐药性的作用

Shilei Zhang1,2,3, Ting Dou1,2,4, Hong Li1,2

  • 1Department of Radiation Oncology, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot, 010020, China.

Hereditas
|December 28, 2024
PubMed
概括

低调胰岛素样生长因子2结合蛋白2 (IGF2BP2) 可以通过降低Spondin 2 (Spon2) 表达来克服肺癌中西斯普拉丁的耐药性. 这为治疗抗西斯普拉丁肺癌提供了潜在的新策略.